kabutan

Nippon Shinyaku Co.,Ltd.(4516) Summary

4516
TSE Prime
Nippon Shinyaku Co.,Ltd.
4,765
JPY
-124
(-2.54%)
Apr 30, 10:49 am JST
29.73
USD
Apr 29, 9:49 pm EDT
Result
PTS
outside of trading hours
4,763
Apr 30, 10:47 am JST
Summary Chart Historical News Financial Result
PER
12.2
PBR
1.13
Yield
2.60%
Margin Trading Ratio
6.79
Stock Price
Apr 30, 2026
Opening Apr 30, 9:00 am
4,887 JPY 30.50 USD
Previous Close Apr 28
4,889 JPY 30.70 USD
High Apr 30, 9:00 am
4,910 JPY 30.65 USD
Low Apr 30, 10:47 am
4,762 JPY 29.70 USD
Volume
67,700
Trading Value
0.33B JPY 2.04M USD
VWAP
4836.25 JPY 30.18 USD
Minimum Trading Value
476,500 JPY 2,973 USD
Market Cap
0.33T JPY 2.09B USD
Number of Trades
450
Liquidity & Number of Trades
As of Apr 30, 2026
Liquidity
High
1-Year Average
1,493
1-Year High Dec 8, 2025
46,428
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 8,900 78,500 8.82
Apr 17, 2026 9,100 75,600 8.31
Apr 10, 2026 8,200 76,200 9.29
Apr 3, 2026 9,100 82,900 9.11
Mar 27, 2026 9,200 82,700 8.99
Company Profile
Nippon Shinyaku Co., Ltd. primarily focuses on prescription pharmaceuticals, with strengths in urology and cardiovascular fields. The company also operates in the functional food business.
Sector
Pharmaceuticals
Nippon Shinyaku Co., Ltd. centers its operations on the pharmaceutical business, primarily targeting medical professionals, while also expanding into the functional food sector. In the pharmaceutical business, the company manufactures and sells its own products, and its subsidiary, Sioe Pharmaceutical Co., Ltd., also engages in manufacturing and sales. Tajima Food Co., Ltd. manufactures raw materials and supplies them to Nippon Shinyaku. Overseas, the U.S. subsidiary is responsible for pharmaceutical sales, out-licensing, and clinical development, while the Chinese subsidiary provides business support and sales services. In the functional food business, Nippon Shinyaku manufactures and sells its own products, with Tajima Food Co., Ltd. handling contract manufacturing. The company also receives product supplies from Sioe Pharmaceutical Co., Ltd. Furthermore, the subsidiary Nippon Shinyaku Advance Co., Ltd. provides business support, insurance agency services, real estate leasing, and educational support services.